Spots Global Cancer Trial Database for randomization
Every month we try and update this database with for randomization cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| A Prospective, Randomized, Multicenter, Comparative Study of the Efficacy of Imatinib Resumption Combined With Atezolizumab Versus Imatinib Resumption Alone in Patients With Unresectable Advanced Gastrointestinal Stromal Tumors (GIST) After Failure of Standard Treatments | NCT05152472 | Unresectable Ga... Locally Advance... Metastatic Gast... | Atezolizumab 12... Imatinib 400 MG | 18 Years - | Centre Leon Berard | |
| Efficacy of metfOrmin in PrevenTIng Glucocorticoid-induced Diabetes in Patients With Brain Metastases | NCT04001725 | Brain Metastase... Melanoma Lung Cancer Breast Cancer | Dexamethasone Metformin | 18 Years - 75 Years | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | |
| Efficacy of Regorafenib Combined With Best Supportive Care as Maintenance Treatment in High Grade Bone Sarcomas Patients | NCT04698785 | Bone Sarcoma Osteosarcoma | Treatment by re... Treatment by pl... | 12 Years - | Centre Leon Berard | |
| Efficacy and Safety of Regorafenib as Maintenance Therapy After First-line Treatment in Patients With Bone Sarcomas | NCT04055220 | Bone Sarcoma Osteosarcoma Ewing Sarcoma Chondrosarcoma Undifferentiate... Leiomyosarcoma Angiosarcoma | Treatment by Re... Treatment by Pl... | 12 Years - | Centre Leon Berard | |
| Study of PEP02, Irinotecan or Docetaxel in Gastric or Gastroesophageal Junction Adenocarcinoma | NCT00813072 | Stomach Neoplas... Esophageal Neop... | PEP02 irinotecan docetaxel | 18 Years - | PharmaEngine | |
| Study of Radiation Fractionation on Patient Outcomes After Breast REConstruction (FABREC) for Invasive Breast Carcinoma | NCT03422003 | Breast Cancer | Radiation Thera... | 18 Years - | Dana-Farber Cancer Institute | |
| Study Comparing TIL to Standard Ipilimumab in Patients With Metastatic Melanoma | NCT02278887 | Metastatic Mela... | Translational r... Cyclophosphamid... Fludarabine Interleukin-2 Ipilimumab infu... | 18 Years - 75 Years | The Netherlands Cancer Institute | |
| Study Comparing TIL to Standard Ipilimumab in Patients With Metastatic Melanoma | NCT02278887 | Metastatic Mela... | Translational r... Cyclophosphamid... Fludarabine Interleukin-2 Ipilimumab infu... | 18 Years - 75 Years | The Netherlands Cancer Institute | |
| A Multicenter Trial Comparing Induction C/T Followed by CCRT v.s. CCRT Alone in Stage IV Nasopharyngeal Carcinoma | NCT00201396 | Nasopharyngeal ... | CCRT Mitomycin C,Epi... | - 70 Years | National Health Research Institutes, Taiwan | |
| Study of Radiation Fractionation on Patient Outcomes After Breast REConstruction (FABREC) for Invasive Breast Carcinoma | NCT03422003 | Breast Cancer | Radiation Thera... | 18 Years - | Dana-Farber Cancer Institute | |
| Efficacy of Regorafenib Combined With Best Supportive Care as Maintenance Treatment in High Grade Bone Sarcomas Patients | NCT04698785 | Bone Sarcoma Osteosarcoma | Treatment by re... Treatment by pl... | 12 Years - | Centre Leon Berard | |
| Comparison of Consolidation Strategies for Pediatric Patients With Acute Myeloid Leukemia | NCT06211452 | AML Pediatric AML | ARM A: Active C... ARM B: Blocks T... | - 18 Years | Grupo Argentino de Tratamiento de la Leucemia Aguda | |
| A Multicenter Trial Comparing Induction C/T Followed by CCRT v.s. CCRT Alone in Stage IV Nasopharyngeal Carcinoma | NCT00201396 | Nasopharyngeal ... | CCRT Mitomycin C,Epi... | - 70 Years | National Health Research Institutes, Taiwan | |
| Dedicated MR Imaging vs Surgical Staging of Peritoneal Carcinomatosis in Colorectal Cancer | NCT04231175 | Colorectal Canc... Peritoneal Carc... MRI | DWI MRI of the ... | 18 Years - | The Netherlands Cancer Institute | |
| Efficacy of the Combination of Nivolumab and Ipilimumab as a Treatment in Patients With Sarcoma of Rare Subtype | NCT04741438 | Sarcoma | Nivolumab and I... Pazopanib Oral ... | 18 Years - | Centre Leon Berard | |
| Efficacy and Safety of Regorafenib as Maintenance Therapy After First-line Treatment in Patients With Bone Sarcomas | NCT04055220 | Bone Sarcoma Osteosarcoma Ewing Sarcoma Chondrosarcoma Undifferentiate... Leiomyosarcoma Angiosarcoma | Treatment by Re... Treatment by Pl... | 12 Years - | Centre Leon Berard | |
| Transperineal MRI-TRUS Fusion Guided Prostate Biopsy With vs Without Antibiotic Prophylaxis | NCT04146142 | Prostate Biopsy Antibiotic | Transperineal p... | - | Oslo University Hospital | |
| Efficacy of the Combination of Nivolumab and Ipilimumab as a Treatment in Patients With Sarcoma of Rare Subtype | NCT04741438 | Sarcoma | Nivolumab and I... Pazopanib Oral ... | 18 Years - | Centre Leon Berard | |
| Efficacy of the Combination of Nivolumab and Ipilimumab as a Treatment in Patients With Sarcoma of Rare Subtype | NCT04741438 | Sarcoma | Nivolumab and I... Pazopanib Oral ... | 18 Years - | Centre Leon Berard |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
